DV
Dynavax Technologies Corporation
DVAX · NASDAQ
$15.50 +0.00% (+$0.00)
Market Cap $1.82B
P/E Ratio -
Div. Yield -
ROE 8.05%
Bulios Fair Price
$16.03
3.4% upside
Trenutna cena
$15.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica DVAX trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
54 /100
Fair P/FCF 22.60x
P/S 5.51x
P/B 3.41x
Growth
100 /100
Growing Book val. growth 312.30%
Rev. growth 173.77%
FCF growth N/A
Profitability
54 /100
Moderate Op. margin 3.16%
Gross margin 83.17%
FCF margin 24.37%
Quality
5 /100
Poor ROA 4.59%
ROIC 1.27%
Asset turnover 0.35x
Debt
74 /100
Low Int. coverage -5.28x
Debt/Equity 0.53x
Net debt/EBITDA -4.86x
Stability
27 /100
Unstable EPS volatility 92.02%
Beta 0.93x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DVAX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ryan Spencer
Employees
405
Headquarters
EmeryVille